The clinical diagnosis of coronary embolism has attracted serious consideration only in recent years. Following Virchow's (1856) original post-mortem description, the view persisted for almost a century that coronary embolism was a rare, almost invariably fatal event (Garvin & Work 1939 , Schrader et al. 1956 ), usually associated with infective endocarditis or intracardiac mural thrombi (Wenger & Bauer 1958) . After the initial cases reported during life (Ivanov 1941 , Mussafia 1948 , evidence accumulated that non-fatal coronary embolism may be underdiagnosed rather than rare, and in a recent study (Prizel et al. 1978) 13% of a consecutive autopsy series of patients with myocardial infarction were shown to have suffered embolic infarcts. Cardiac catheterization, coronary angiography and prosthetic valve replacement introduced in the 1960s offered new techniques for the study of coronary occlusion and a new source of coronary emboli. However, the clinical significance of non-fatal coronary embolism remains controversial: De Nevasquez (1939) and Hamman (1941) suggested that although a relatively frequent autopsy finding, it was rarely responsible for myocardial infarction; whilst others have described an important incidence of myocardial infarction (Prizel et al. 1978) , subsequent angina pectoris (Oakley et al. 1961) , heart failure and other sequelae (Benchimol & Sandoval 1971 , Charles et al. 1982 .
The conflict of evidence is at least partly due to the difficulty in making a clinical diagnosis of coronary embolism. A recent study of coronary embolism in valvular heart disease has suggested that in some patients a history of myocardial infarction may be atypical or absent, whilst in others electrocardiographic changes are only transient (Charles et al. 1982) . This paper reviews the diagnosis of coronary embolism and its therapeutic implications. Table I summarizes the causes of coronary embolism in the four main autopsy studies reported in the literature (Hamman 1941 , Wenger & Bauer 1958 , Loire et al. 1977 , Prizel et al. 1978 . Before 1960, infective endocarditis accounted for more than half of all cases but has declined in importance; non-infected valvular heart disease is now the most frequent cause of coronary embolism. In a study of coronary embolism in· valvular heart disease, which included 20 patients diagnosed clinically (Charles et al. 1982) , coronary embolism was related particularly to atrial fibrillation and mitral valve disease, combined aortic and mitral valve disease and the presence of a prosthetic heart valve. A third major group includes patients prone to the development of mural thrombus in the left ventricle due to idiopathic dilated cardiomyopathy or to the effects of coronary artery disease (Prizel et al. 1978) . Cardiac catheterization, especially coronary arteriography, is the major cause of iatrogenic coronary embolism (Roberts 1978) . Rarer causes include neoplastic, bone marrow, paradoxical and air emboli, and fragments of suture material or talc following open heart surgery (Roberts 1978) .
Causes of coronary embolism

Pathological features of coronary embolism
As Roberts (1978) has pointed out, the consequences of coronary embolism depend upon the size of the embolus and the size of the artery in which it becomes impacted ( Figure 1) . A large embolus ( Figure IA ) will impact proximally in the orifice of a major coronary artery, resulting in abrupt cessation of blood flow and myocardial necrosis or fatal arrhythmia. A smaller embolus will lodge more distally ( Figure IB ) usually causing limited infarction in the epicardial region where collateral flow between vessels is relatively poor. If the embolus is so small that only a single intramyocardial branch is occluded, the extensive collateral supply will prevent myocardial necrosis and the event will be clinically silent ( Figure Ie ). An embolus occluding several intramyocardial branches may be similarly silent, but if secondary thrombosis extends back to occlude the coronary trunk, varying degrees of myocardial necrosis will ensue depending upon the site and adequacy of collateral flow ( Figure ID) . The site at which an embolus impacts will also be affected by the presence of coexisting atherosclerotic narrowing of the coronary artery. Two-thirds of clinically-diagnosed emboli produce transmural infarction and one-third produce non-transmural infarction (Charles et a/. 1982) . Three-quarters of embolic infarcts are anterior (Wenger & Bauer 1958 , Prizel et a/. 1978 , Charles et a/. 1982 , probably due to haemodynamic factors which favour diastolic blood flow into the left coronary artery (Schlesinger & Zoll 1941 , Pesendorfer 1969 . The subsequent fate of the impacted embolus gives rise to what is perhaps the principal difficulty in proving a diagnosis of coronary embolism during life. Lysis, retraction, recanalization or fragmentation with distal dispersion of the embolus sufficient to allow a Figure I . Effect of the site of impaction of the coronary embolus on myocardial necrosis (modified from Roberts 1978) normal angiographic appearance of the affected vessel may be extremely rapid. Normal coronary arteriography has been demonstrated within 4 weeks of documented coronary embolism caused by cardiac catheterization (Richardson & Gotsman 1971) , and resolution of a catheter induced renal artery embolism occurred within 4 days (McConnell et al. 1973) . Therefore unless early coronary arteriography is undertaken to prove the presence of the embolus, the diagnosis will be circumstantial and rest upon the coexistence of a source for embolism and the demonstration of angiographically normal coronary arteries.
Clinical features
Coronary embolic occlusion may present clinically in one of four ways. Typically, the diagnosis should be considered when a patient with a condition predisposing to systemic embolism suffers either sudden death or retrosternal chest pain accompanied by the electrocardiographic and enzyme changes of acute myocardial infarction. However, nearly one-third of 23 embolic episodes in patients with valvular heart disease described by Charles et al. (1982) had atypical modes of presentation. New symptoms, particularly increased dyspnoea or congestive cardiac failure, may develop in association with electrocardiographic evidence of myocardial infarction, chest pain being atypical or absent. Lastly, the electrocardiographic changes of transmural infarction may appear in routine follow-up tracings unassociated with any identifiable symptomatic event and with the subsequent demonstration of normal coronary arteries. Atypical presentation is not, of course, peculiar to coronary embolic infarction. Approximately 25% of myocardial infarcts are unrecognized either because mild symptoms are ignored by the patient or because no symptoms occurred (Margolis et al. 1973) . Atypical presentations of acute myocardial infarction commonly include acute dyspnoea or congestive cardiac failure -either newly developing or a worsening of established failure (Bean 1977 , Uretsky et al. 1977 ) -symptoms which could easily be attributed to the progression of valvular heart disease or infective endocarditis if the possibility of coronary embolic infarction were not considered in these conditions. Patients with coronary embolism may have a history of other systemic emboli (Charles et al. 1982 ) since the underlying conditions are those which predispose to systemic embolism as a whole. The incidence of coronary risk factors may also be low (Charles et al. 1982) . Unless the embolus has occurred because of ischaemic left ventricular dyskinesia, embolic infarction is usually an isolated coronary event with no preceding or subsequent symptoms of ischaemic heart disease. However, late sequelae may include increased dyspnoea, cardiac failure and ventricular aneurysm (Charles et al. 1982) . Oakley et al. (1961) suggested that coronary embolism was the commonest cause of angina pectoris in mitral stenosis, but this has not been generally confirmed. Angina pectoris following coronary embolism can usually be attributed to coexistent atheromatous coronary artery disease or aortic valve disease.
Electrocardiographic changes
Depending upon the site of occlusion within the coronary artery, the electrocardiogram may reflect transmural infarction with the development of pathological Q waves or nontransmural infarction in which abnormalities of repolarization occur. In the authors' study (Charles et al. 1982 ) 70% of embolic episodes resulted in permanent changes of transmural infarction, while 30% (7 of 23 episodes) produced only T-wave changes accompanied by elevation of cardiac enzymes. In 6 of the 7 non-transmural infarctions the T wave abnormalities resolved within 2 weeks to 19 months of the embolic episode. The following brief case report illustrates some of the electrocardiographic and symptomatic difficulties which may conceal the diagnosis of coronary embolism.
Case report
A 62-year-old woman with rheumatic mitral and aortic valve disease developed acute breathlessness on 22 February 1975. Effort dyspnoea had been present for 2 years but at no time had she experienced chest pain. The ECG (Figure 2 ) showed atrial fibrillation, digitalis effect and Q waves in leads I, aVL and V5-6 of remote anterolateral myocardial infarction. This patient presumably had two episodes of coronary embolism. The first resulted in anterolateral transmural infarction but was unaccompanied by an appropriate history. The second presented with atypical symptoms and resulted in non-transmural infarction further contributing to left ventricular dysfunction. If the diagnosis of coronary embolism had not been suspected, the presenting symptoms may have been attributed to valvular heart disease and the electrocardiographic changes to coexistent atheromatous coronary artery disease.
Angiography
Final proof that acute myocardial infarction has been due to coronary embolism can only be obtained by pathological examination, unless it is clearly documented that embolism occurred during cardiac catheterization. The rapidity with which resolution of embolus may occur means that selective coronary arteriography may fail to demonstrate the embolus unless it is performed within days ( < I month) of embolization. Table 2 lists 4 studies of accidental catheter-induced coronary embolic infarctions with subsequently normal coronary arteries. The earliest study was performed 4 weeks after occlusion. When selective coronary angiography demonstrates an occlusion of a major coronary artery the site of occlusion may help to distinguish between embolus and thrombosis on an atherosclerotic plaque. An embolus migrates distally as far as it can travel and tends to be situated in the distal half of the coronary trunk, most commonly in the left anterior descending coronary artery, and to involve the small branches of the main trunk. By contrast, thrombus is usually situated more proximally in the coronary artery superimposed upon atherosclerotic plaque, which extensively affects other major coronary arteries (Roberts & Buja 1972) . If the embolus is not demonstrated by coronary arteriography, the combination of acute myocardial infarction with angiographically-normal coronary arteries and an underlying source for embolism constitutes circumstantial evidence for a diagnosis of coronary embolism. Myocardial infarction is most often due to atherosclerosis (Roberts & Buja 1972 , Ridolfi & Hutchins 1977 : coronary arteriography in patients with symptomatic ischaemic heart disease shows that at least one and usually two major coronary arteries are narrowed by more than 75% as a result of atherosclerosis (Hale et al. 1966 , Ross & Friesinger 1966 . However, between I% and 11 % of patients have 'myocardial infarction with normal coronary arteries', a syndrome of uncertain aetiology. Arnett & Roberts (1976) have argued that an angiographically-normal coronary vasculature has never been demonstrated in the acute phase of myocardial infarction, and that in patients with supposed myocardial infarction and normal coronary arteries the arteriograms were performed during healing rather than during the acute infarct. Whilst coronary artery spasm has been implicated in a wide range of clinical syndromes and may occur in large epicardial arteries which are free from atheroma, these authors argue that coronary embolism is the most reasonable explanation. Supporting evidence includes the relatively high incidence of conditions associated with an increased risk of arterial thromboemboli in this group (Arnett & Roberts 1976) , the rapidity of angiographic resolution of coronary emboli and the absence of recurrent variant angina pectoris, the typical clinical manifestation of coronary spasm.
Implications for management
The diagnosis of coronary embolism as a cause for acute myocardial infarction may have implications for immediate and long-term management which differ from those pertaining to atheromatous coronary occlusion.
Acute management
Immediate anticoagulation is usually indicated to prevent secondary thrombosis and, where relevant, to reduce the possibility of recurrent emboli. Coronary vasodilators such as isosorbide or nifedipine could theoretically improve distal circulation, promote movement of the embolus to a more distal site and relieve local arterial spasm at the site of the embolus.
In life-threatening cases the possibility of surgical embolectomy has been raised (Berger et al. 1972) . A more practical proposition may be selective intracoronary thrombolysis using streptokinase, a technique which has been successfully used during the first few hours of myocardial infarction. Coronary arteriography is first performed to identify the site of obstruction, and streptokinase is then infused selectively into the affected coronary artery, sometimes preceded by mechanical disobliteration using a guide wire (Rentrop et al. 1981) . The value of this technique would depend partly upon the composition of the embolus.
Long-term management
Removal of the source of embolism or prevention of further emboli should be the long-term aims. Surgical management of infective endocarditis, atrial tumours or left ventricular aneurysm should receive early consideration. In valvular heart disease without infective endocarditis the factors predisposing to coronary emboli. are those which predispose to systemic embolism as a whole (Charles et al. 1982) . Cong-term anticoagulation with warfarin is indicated to reduce the incidence of further embolism. Systemic thromboembolism is a complication in 5-10% of patients with prosthetic heart valves (Weily et al. 1974 ). Oral anticoagulants have reduced but not eliminated thromboembolic complications related to decreased platelet survival time (Weily et al. 1974) . In patients with prosthetic heart valves, antiplatelet drugs such as dipyridamole, aspirin and sulphinpyrazone correct shortened platelet survival and have reduced the risk of thromboembolism when used in combination with anticoagulants (Sullivan et al. 1971 , Dale et al. 1977 , Weiss 1978 ). Longterm warfarin and dipyridamole have been used by Charles et al. (1982) in patients with coronary embolism related to a prosthetic heart valve.
Experience of the acute and long-term management of coronary embolic myocardial infarction is extremely limited. Improved awareness of the condition should help to clarify its natural history and therapeutic possibilities.
Summary
Coronary embolism is an uncommon but distinct clinical entity. It can be diagnosed clinically, and should be suspected when acute myocardial infarction occurs in association with an underlying condition which predisposes to embolism. The most common are valvular heart disease, a prosthetic heart valve, infective endocarditis, cardiomyopathy with mural thrombus and arrhythmia. The diagnosis may be obscured by atypical symptoms and transient ECG changes. The diagnosis is supported by the demonstration of normal coronary arteries by selective coronary arteriography. Treatment with long-term anticoagulants may prevent further emboli. Additional antiplatelet drugs are also necessary in patients with prosthetic heart valves.
